Surotomycin

N/A

Report date: 2022/07/04 19:38:02
NMEQIDP

Base Information

Drug NameSurotomycin
Drug Alias Namesurotomycine่ˆ’ๆ‰˜้œ‰็ด CDAD therapy - Cubist่ˆ’็ฝ—ๆ‰˜้œ‰็ด surotomycinum +[10]ย 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Lipopeptide antibioticsSmall molecules > Synthetic peptide
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsDiarrheaClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCubist Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCubist Pharmaceuticals LlcMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsDiarrheaClostridium Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG